FDA inspection
CIT Co., Ltd.: FDA inspection ending Dec 8, 2023
FDA inspection 1228817 · Voluntary Action Indicated (VAI) · Tangjin
Key facts
| Inspection ID | 1228817 |
|---|---|
| Firm | CIT Co., Ltd. |
| FEI number | 3008160676 |
| Address | 110 Hapdeoksandan 1-ro, Hapdeok-eup |
| City | Tangjin |
| Country | Korea (the Republic of) |
| Fiscal year | 2024 |
| Inspection end date | Dec 8, 2023 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data